Concomitant usage of NORCO Tablets with CYP3A4 inducers or discontinuation of the CYP3A4 inhibitor could reduce hydrocodone plasma concentrations, lessen opioid efficacy or, potentially, produce a withdrawal syndrome in a patient who had developed physical dependence to hydrocodone. Individually titrate NORCO into a dose that gives satisfactory analgesia and minimizes https://nonprescriptionsmedsonline.com/contact/